Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 2
1999 1
2000 1
2001 1
2003 1
2010 1
2011 1
2013 1
2014 4
2015 4
2016 4
2017 4
2018 1
2019 3
2020 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
DKK1 and sclerostin are early markers of relapse in multiple myeloma.
Mabille C, Ruyssen-Witrand A, Degboe Y, Gennero I, Loiseau HA, Roussel M, Hebraud B, Nigon D, Attal M, Laroche M. Mabille C, et al. Among authors: nigon d. Bone. 2018 Aug;113:114-117. doi: 10.1016/j.bone.2017.10.004. Epub 2017 Oct 6. Bone. 2018. PMID: 28993177 Clinical Trial.
Prevalence and risk factors for fragility fracture in systemic mastocytosis.
Degboé Y, Eischen M, Nigon D, Apoil PA, Mailhol C, Tournier E, Laurent C, Hanssens K, Hermine O, Paul C, Laroche M, Bulai-Livideanu C. Degboé Y, et al. Among authors: nigon d. Bone. 2017 Dec;105:219-225. doi: 10.1016/j.bone.2017.09.005. Epub 2017 Sep 14. Bone. 2017. PMID: 28919366
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients.
Luxembourger C, Ruyssen-Witrand A, Ladhari C, Rittore C, Degboe Y, Maillefert JF, Gaudin P, Marotte H, Wendling D, Jorgensen C, Cantagrel A, Constantin A, Nigon D, Touitou I, Gottenberg JE, Pers YM. Luxembourger C, et al. Among authors: nigon d. Pharmacogenomics J. 2019 Aug;19(4):368-374. doi: 10.1038/s41397-019-0072-6. Epub 2019 Jan 16. Pharmacogenomics J. 2019. PMID: 30647443
31 results